Important Updates on the ViroStat Integration Into Medix Biochemica

In 2023, Medix Biochemica acquired ViroStat to better serve the infectious disease market’s raw material needs with best in class antibody & antigen products.

As part of our integration process, we will be making some changes to order processes and branding that will apply to all ViroStat portfolio products.

In case your company has a Supply or Distributor Agreement in place with Virostat Inc., and you wish to officially amend it to accommodate the changes, please contact your Medix Biochemica representative or reach out to us at medix@medixbiochemica.com.

ViroStat

It is important to note that there will be no changes to:

  • The form, fit, or function of any products
  • The manufacturing entity, location, processes, or team members that build and ensure the quality of our products

What will be changing?

As from October 1, 2024 the following changes will come into effect:

Minor change in ViroStat product catalogue numbers

As part of ViroStat’s migration to Medix Biochemica’s ERP system, we will be making a minor change to the catalogue numbers of the ViroStat product range. 

Change in order process for ViroStat products

All orders for ViroStat products must be placed to Medix Biochemica, orders@medixbiochemica.com. You may need to implement a new vendor registration process as part of this change. Our team will be available to support you with this.

Change in format of Product Specifications & COA documents for ViroStat products

We will be aligning the format of the product specification and certificate of analysis documents to current Medix Biochemica templates.

Change in logo and branding for ViroStat products

As part of our global brand harmonization project, all product sales documents (sales confirmations, packing slips and invoices), all product quality assurance documents (certificates of analysis, data and specifications sheets) and all product labelling that was previously branded as ViroStat, will be branded as Medix Biochemica.

This change applies to all ViroStat products, Certificates of Analysis, product specifications, and product labelling.

What is in scope of the change?

Document Parameter Current ViroStat Document New Medix Biochemica Document
Catalogue / Item Number
Bulk item
(≥1mg/mL concentration)
Item No: 1234 Item No: V1234
Catalogue / Item Number
Sample / research item
(100µg/mL concentration)
Item No: 1234 Item No: V1234S
Product Description
Product type
MonoTope / OmniTope / MabyRab
product descriptions
Not included / used on new documents
Product Description
Antibody abbreviation
Aby Anti
Logo

VIROSTAT.logo

Medix-logo

Our primary objective remains the continuity of product quality, service, and delivery that you have relied on for years.

Should you have any questions, please contact your Medix Biochemica sales representative or call a member of our Customer Service:

USA              1-314-968-1091

Finland       +358 9 547680

Alternatively, we can be reached by email at: medix@medixbiochemica.com.

Key documents for more information

PRODUCT AND BRANDING UPDATES

Scope of changes

LIST OF THE PRODUCTS WITH NEW ITEM NUMBERS

Virostat product list

PRODUCT SPECIFICATION EXAMPLES

Example product V0631

Example product V0631S

ORDERING UPDATES

New Vendor Process